Neoplasms derived from plasmacytoid dendritic cells.
Brescia, Italy. In Mod Pathol, Feb 2016
In this tumor, which is characterized by a distinctive cutaneous and bone marrow tropism, proliferating cells derive from immediate CD4(+)CD56(+) precursors of plasmacytoid dendritic cells.
L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets.
Milano, Italy. In Trends Pharmacol Sci, Nov 2015
L1 cell adhesion molecule (L1-CAM) and neural cell adhesion molecule (N-CAM), key members of the immunoglobulin-like CAM (Ig-CAM) family, were first recognized to play critical roles in surface interactions of neurons, by binding with each other and with extracellular matrix (ECM) proteins.
Monoclonal antibodies in myeloma.
Gießen, Germany. In Clin Adv Hematol Oncol, Sep 2015
Our review focuses on a small number of promising mAbs directed against molecules on the surface of myeloma cells, including CS1 (elotuzumab), CD38 (daratumumab, SAR650984, MOR03087), CD56 (lorvotuzumab mertansine), and CD138/syndecan-1 (BT062/indatuximab ravtansine).
Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population.
Southampton, United Kingdom. In Lancet, Mar 2015
Mononuclear cells were isolated by ficoll separation and cell surface staining performed for CD3, CD56, CD16, CD57, CD117, CD161, CD158a, CD158b, CD49a, CD49b, CXCR6, NKG2C, and NKp46.
Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides.
More papers using
Bursa, Turkey. In J Immunol Res, 2014
Fluorescent labeled monoclonal antibodies were used to detect cell surface antigens: T cells (CD3(+), CD4(+), CD8(+), TCRαβ (+), TCRγδ (+), CD7(+), CD4(+)CD7(+), CD4(+)CD7(-), and CD71(+)), B cells (HLA-DR(+), CD19(+), and HLA-DR(+)CD19(+)), NKT cells (CD3(+)CD16(+)CD56(+)), and NK cells (CD3(-)CD16(+)CD56(+)).
BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction
In The Journal of Experimental Medicine, 1999
... using mAb against CD3 (mAb SK9, IgG2b; Becton Dickinson), CD19 (mAb 4G7, IgG1; Becton Dickinson), CD56 (mAb MY31, IgG1; Becton Dickinson), and CD14 (mAb MφP9, ...